MedTrace Logo

Vitamin D and Immune Mechanisms of Hypertension in Type 2 Diabetics

NCT03348280 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2025-12-24

No results posted yet for this study

Summary

This trial will evaluate whether a particular type of circulating white blood cell, monocytes, from type 2 diabetics with high blood pressure and vitamin D deficiency vs. sufficiency will induce hormones that increase blood pressure.

Conditions

  • Diabetes Mellitus, Type 2
  • Hypertension
  • Vitamin D Deficiency

Interventions

DIAGNOSTIC_TEST

Blood draw

Blood will be drawn to isolate monocytes after 2 weeks off of blood pressure lowering medications.

Sponsors & Collaborators

  • Washington University School of Medicine

    lead OTHER

Principal Investigators

  • Carlos Bernal-Mizrachi, MD · Washington University School of Medicine

Eligibility

Min Age
25 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-09-01
Primary Completion
2026-12-31
Completion
2026-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03348280 on ClinicalTrials.gov